Triple labelling of plasma endothelial EVs with CD31, CD51/61 (integrin αV/β3) and CD54 demonstrated increased levels of activated endothelial EVs (CD31+CD51/61+CD54+) in RRMS, but not in SPMS patients. This evidence concerns the gene ITGAV and secondary progressive multiple sclerosis.